Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6

Ryo Ueda, Eiko Kinoshita, Rena Ito, Takeshi Kawase, Yutaka Kawakami, Masahiro Toda

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We previously reported identifying SOX6 as a glioma antigen by serological screening using a testis cDNA library. Its preferential expression and frequent IgG responses in glioma patients indicate that SOX6 may be a useful target for immunotherapy. To examine whether cytotoxic T-lymphocyte (CTL) responses specific for SOX6 to destroy glioma can be generated in vivo, we treated glioma-bearing mice by vaccination with a plasmid DNA encoding murine full-length SOX6 protein. Following SOX6-DNA vaccination, CTLs specific for SOX6-expressing glioma cells were induced, while normal autologous-cells that had restrictedly expressed SOX6 during embryogenesis were not destroyed. Furthermore, DNA vaccination with SOX6 exerted protective and therapeutic antitumor responses in the glioma-bearing mice. This antitumor activity was abrogated by the depletion of CD4 positive T cells and/or CD8 positive T cells. These results suggest that the SOX6 protein has multiple CTL and helper epitopes to induce antitumor activity and the effectiveness of SOX6-DNA vaccine for the prevention and treatment of glioma.

Original languageEnglish
Pages (from-to)2274-2279
Number of pages6
JournalInternational Journal of Cancer
Volume122
Issue number10
DOIs
Publication statusPublished - 2008 May 15

Fingerprint

DNA Vaccines
Glioma
Immunity
Antigens
Vaccination
Cytotoxic T-Lymphocytes
Therapeutics
DNA
T-Lymphocytes
T-Lymphocyte Epitopes
Gene Library
Immunotherapy
Embryonic Development
Testis
Proteins
Plasmids
Immunoglobulin G

Keywords

  • Antitumor immunity
  • CTL response
  • DNA vaccine
  • Glioma antigen
  • SOX6

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6. / Ueda, Ryo; Kinoshita, Eiko; Ito, Rena; Kawase, Takeshi; Kawakami, Yutaka; Toda, Masahiro.

In: International Journal of Cancer, Vol. 122, No. 10, 15.05.2008, p. 2274-2279.

Research output: Contribution to journalArticle

Ueda, Ryo ; Kinoshita, Eiko ; Ito, Rena ; Kawase, Takeshi ; Kawakami, Yutaka ; Toda, Masahiro. / Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6. In: International Journal of Cancer. 2008 ; Vol. 122, No. 10. pp. 2274-2279.
@article{3d0a1e5a4ade43188744b598a7c84953,
title = "Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6",
abstract = "We previously reported identifying SOX6 as a glioma antigen by serological screening using a testis cDNA library. Its preferential expression and frequent IgG responses in glioma patients indicate that SOX6 may be a useful target for immunotherapy. To examine whether cytotoxic T-lymphocyte (CTL) responses specific for SOX6 to destroy glioma can be generated in vivo, we treated glioma-bearing mice by vaccination with a plasmid DNA encoding murine full-length SOX6 protein. Following SOX6-DNA vaccination, CTLs specific for SOX6-expressing glioma cells were induced, while normal autologous-cells that had restrictedly expressed SOX6 during embryogenesis were not destroyed. Furthermore, DNA vaccination with SOX6 exerted protective and therapeutic antitumor responses in the glioma-bearing mice. This antitumor activity was abrogated by the depletion of CD4 positive T cells and/or CD8 positive T cells. These results suggest that the SOX6 protein has multiple CTL and helper epitopes to induce antitumor activity and the effectiveness of SOX6-DNA vaccine for the prevention and treatment of glioma.",
keywords = "Antitumor immunity, CTL response, DNA vaccine, Glioma antigen, SOX6",
author = "Ryo Ueda and Eiko Kinoshita and Rena Ito and Takeshi Kawase and Yutaka Kawakami and Masahiro Toda",
year = "2008",
month = "5",
day = "15",
doi = "10.1002/ijc.23366",
language = "English",
volume = "122",
pages = "2274--2279",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Induction of protective and therapeutic antitumor immunity by a DNA vaccine with a glioma antigen, SOX6

AU - Ueda, Ryo

AU - Kinoshita, Eiko

AU - Ito, Rena

AU - Kawase, Takeshi

AU - Kawakami, Yutaka

AU - Toda, Masahiro

PY - 2008/5/15

Y1 - 2008/5/15

N2 - We previously reported identifying SOX6 as a glioma antigen by serological screening using a testis cDNA library. Its preferential expression and frequent IgG responses in glioma patients indicate that SOX6 may be a useful target for immunotherapy. To examine whether cytotoxic T-lymphocyte (CTL) responses specific for SOX6 to destroy glioma can be generated in vivo, we treated glioma-bearing mice by vaccination with a plasmid DNA encoding murine full-length SOX6 protein. Following SOX6-DNA vaccination, CTLs specific for SOX6-expressing glioma cells were induced, while normal autologous-cells that had restrictedly expressed SOX6 during embryogenesis were not destroyed. Furthermore, DNA vaccination with SOX6 exerted protective and therapeutic antitumor responses in the glioma-bearing mice. This antitumor activity was abrogated by the depletion of CD4 positive T cells and/or CD8 positive T cells. These results suggest that the SOX6 protein has multiple CTL and helper epitopes to induce antitumor activity and the effectiveness of SOX6-DNA vaccine for the prevention and treatment of glioma.

AB - We previously reported identifying SOX6 as a glioma antigen by serological screening using a testis cDNA library. Its preferential expression and frequent IgG responses in glioma patients indicate that SOX6 may be a useful target for immunotherapy. To examine whether cytotoxic T-lymphocyte (CTL) responses specific for SOX6 to destroy glioma can be generated in vivo, we treated glioma-bearing mice by vaccination with a plasmid DNA encoding murine full-length SOX6 protein. Following SOX6-DNA vaccination, CTLs specific for SOX6-expressing glioma cells were induced, while normal autologous-cells that had restrictedly expressed SOX6 during embryogenesis were not destroyed. Furthermore, DNA vaccination with SOX6 exerted protective and therapeutic antitumor responses in the glioma-bearing mice. This antitumor activity was abrogated by the depletion of CD4 positive T cells and/or CD8 positive T cells. These results suggest that the SOX6 protein has multiple CTL and helper epitopes to induce antitumor activity and the effectiveness of SOX6-DNA vaccine for the prevention and treatment of glioma.

KW - Antitumor immunity

KW - CTL response

KW - DNA vaccine

KW - Glioma antigen

KW - SOX6

UR - http://www.scopus.com/inward/record.url?scp=42149130841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149130841&partnerID=8YFLogxK

U2 - 10.1002/ijc.23366

DO - 10.1002/ijc.23366

M3 - Article

VL - 122

SP - 2274

EP - 2279

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 10

ER -